Cargando…

2430. Comorbidity and Severity of Illness Risk Adjustment for Hospital-Onset Clostridioides difficile Infection

BACKGROUND: Hospital-onset C. difficile infection (HO-CDI) rates are publicly reported. However, patient-level risk factors are not included in the current risk adjustment methodology, and the knowledge as to which risk factors to include is incomplete. This study aimed to determine whether electron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabral, Stephanie, Nadimpalli, Gita, Thom, Kerri, Leekha, Surbhi, Harris, Lisa, Blanco Herrera, Natalia, Harris, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810311/ http://dx.doi.org/10.1093/ofid/ofz360.2108

Ejemplares similares

2389. Assessing the Time Course of Proton Pump Inhibitor Use and Clostridioides difficile Infection
por: Panagos, Katherine, et al.
Publicado: (2019)

793. Expert Panel Consensus Ranking of Comorbid Conditions Causally Related to Clostridioides difficile Infection
por: Goodman, Katherine E, et al.
Publicado: (2020)

563. Association Between Chlorhexidine Gluconate Concentrations and Resistant Bacterial Bioburden on Skin
por: Nadimpalli, Gita, et al.
Publicado: (2019)

2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients
por: Vega, Ana D, et al.
Publicado: (2019)

Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2022)

Observation of D$_{1}$(2430)$^{+}$ and D$_{2}^{*}$(2470) $^{+}$
por: Butler, F, et al.
Publicado: (1994)

2430: Leading diverse and emerging scientists to success (LEADS)
por: Rubio, Doris, et al.
Publicado: (2018)

Mitigating hospital-onset Clostridioides difficile: The impact of an optimized environmental hygiene program in eight hospitals
por: Carling, Philip C., et al.
Publicado: (2023)

488. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridium difficile Infection in Critically Ill Patients
por: Vega, Ana, et al.
Publicado: (2018)

Community-Onset Clostridioides Difficile Infection in Hospitalized Patients in The Netherlands
por: Crobach, M J T, et al.
Publicado: (2019)

Nurse Work Environment and Hospital-Onset Clostridioides difficile Infection
por: Jung, Olivia S., et al.
Publicado: (2023)

The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses
por: Bassotti, Gabrio, et al.
Publicado: (2020)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic
por: Luo, Yuying, et al.
Publicado: (2020)

Occurrence of Blastocystis in Patients with Clostridioides difficile Infection
por: Vega, Laura, et al.
Publicado: (2020)

Early Prognostic Stratification of Clostridioides difficile Infection in the Emergency Department: The Role of Age and Comorbidities
por: Covino, Marcello, et al.
Publicado: (2022)

Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection
por: Herrera, Giovanny, et al.
Publicado: (2021)

Impact of Statewide Prevention and Reduction of Clostridioides difficile (SPARC), a Maryland public health–academic collaborative: an evaluation of a quality improvement intervention
por: Rock, Clare, et al.
Publicado: (2022)

2157. Design, Implementation, and Analysis Considerations for Cluster Randomized Trials in Infection Control and Hospital Epidemiology: A Systematic Review
por: O’Hara, Lyndsay, et al.
Publicado: (2018)

2430. Risk Factors for Mortality among Patients who Present from the Community with Central Line-Associated Bloodstream Infections
por: Oladapo-Shittu, Opeyemi, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

The Effect of a Clinical Pathway on Reducing the Rate of Healthcare-Onset Clostridioides difficile
por: Millard, John W., et al.
Publicado: (2020)

Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections
por: Lee, Ching-Chi, et al.
Publicado: (2022)

Role of diagnostic stewardship in reducing healthcare facility-onset Clostridioides difficile infections
por: Shallal, Anita, et al.
Publicado: (2022)

Role of diagnostic stewardship in reducing healthcare-facility–onset Clostridioides difficile infections
por: Shallal, Anita B., et al.
Publicado: (2023)

1203. Impact of Antimicrobial Stewardship Interventions on Hospital-Onset Clostridioides difficile Infections
por: Kwon, Taesung, et al.
Publicado: (2023)

Analysis of the impact of secondary prophylaxis on Clostridioides difficile recurrence in critically ill adults
por: Connor, Kathryn A, et al.
Publicado: (2020)

Clostridioides difficile infection in the critically ill: what kind of therapy for refractory cases
por: Honore, Patrick M., et al.
Publicado: (2020)

Prevalence of Clostridioides difficile Infection in Critically Ill Patients with Extreme Leukocytosis and Diarrhea
por: Teja, Bijan, et al.
Publicado: (2021)

Microbiota-based markers predictive of development of Clostridioides difficile infection
por: Berkell, Matilda, et al.
Publicado: (2021)

Draft Genome Sequence of Amycolatopsis lurida NRRL 2430, Producer of the Glycopeptide Family Antibiotic Ristocetin
por: Kwun, Min Jung, et al.
Publicado: (2014)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Impact of Two-Step Testing Algorithm on Reducing Hospital-Onset Clostridioides difficile Infections
por: Navalkele, Bhagyashri, et al.
Publicado: (2021)

382. Are errors of omission falsely inflating hospital-onset Clostridioides difficile infection numbers?
por: Parada, Jorge Paiva, et al.
Publicado: (2022)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g2k16ivb99kp1hspfben4r93a9